Ultrasound-Monitored Changes in Achilles Tendinopathy After Extracorporeal Shock Wave Therapy
The Ultrasound-Monitored Changes in Achilles Tendinopathy After Focused Extracorporeal Shock Wave Therapy - a Randomized Sham-Controlled Trial
This study is designed as a randomized, placebo-controlled clinical trial in which we monitor the effects of low-energy focused extracorporeal shockwave therapy (ESWT) in patients with Achilles tendinopathy (AT). Participants will be randomly divided into two groups. ESWT according to selected parameters will be applied to Group A. Group B will receive sham ESWT.
Patients in both groups will have the same program. The research for one patient lasts a total of 8 weeks (2 months) from the initial to the final examination. In the first week, there will be a clinical examination by a physiotherapist, an ultrasonographic examination, and the patient will complete a VISA-A questionnaire. At the end of the examination, the patient will be randomly assigned to group A or B and receive the first application. For the next 4 weeks, additional applications will be performed once a week. The interval between individual applications should be at least 7 days. Thus, a total of 5 applications of ESWT or sham ESWT will be performed. The final examination will take place 3 weeks after the last application and will include the same procedures as for the initial examination.
Обзор исследования
Статус
Условия
Вмешательство/лечение
Подробное описание
This study is designed as a randomized, placebo-controlled clinical trial in which we monitor the effects of low-energy focused extracorporeal shockwave therapy (ESWT) in patients with Achilles tendinopathy (AT). Participants will be randomly divided into two groups. ESWT according to selected parameters will be applied to Group A. Group B will receive sham ESWT.
Patients in both groups will have the same program. The research for one patient lasts a total of 8 weeks (2 months) from the initial to the final examination. In the initial session, there will be a clinical examination by a physiotherapist, which includes case history questions, measuring range of motion (measured by weight-bearing lunge test), functional loading tests (1-leg heel rise test, 1-leg hop test) and an ultrasonographic examination (tendon cross section area and width at the maximal tendon antero-posterior width place). In addition, the patient will complete a VISA-A questionnaire. At the end of the initial session, the patient will be randomly assigned to group A or B and receive the first application. For the next 4 weeks, additional applications will be performed once a week. The interval between individual applications should be at least 7 days. Thus, a total of 5 applications of ESWT or sham ESWT will be performed. The final examination will take place 3 weeks after the last application and will include the same procedures as for the initial examination.
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
-
Prague, Чехия
- University Hospital Motol and 2nd Faculty of Medicine, Charles University
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- the patient complains about Achilles tendon pain, which limits (at least partially) his quality of life during daily activities or sport, and this condition would be referred as a tendinopathy
- the patient's other leg is asymptomatic
- the patient is not aware of the symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)
- the patient has no previous experience with extracorporeal shockwave therapy treatment
Exclusion Criteria:
- the patient has condition which is contraindication for extracorporeal shock wave therapy treatment
- the patient had symptomatical mechanical tendon damage in past (eg. partial or complete rupture due to injury)
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Уход
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Одинокий
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Treatment Group (A)
Group of patients with Achilles tendinopathy which are treated by focused extracorporeal shockwave therapy once a week for 5 weeks.
ESWT parameters: 0,12 mJ/mm2, 10 Hz, 1300 shocks.
|
Intensity 0,12 mJ/mm2, frequency 10 Hz, total number of shocks 1300.
|
|
Фальшивый компаратор: Sham Group (B)
Group of patients with Achilles tendinopathy in which sham extracorporeal shockwave therapy is applied once a week for 5 weeks.
Total applications are 5, applicated weekly.
Sham ESWT parameters are same as in Group A (0,12 mJ/mm2, 10 Hz, 1300 shocks) but with modified applicator which does not allow wave transmission.
|
Intensity 0,12 mJ/mm2, frequency 10 Hz, total number of shocks 1300 - applied with modified applicator which does not allow wave transmission.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Change in Cross-sectional Area at the Place of Maximum Tendon Width
Временное ограничение: Change of initial values at 3 weeks follow up after last application (8th week).
|
Measured by measuring tools in ultrasound machine in cm2.
In linear view is selected maximal width place, then the position of ultrasound head is rotated to horizontal view and in this view cross section area is measured.
|
Change of initial values at 3 weeks follow up after last application (8th week).
|
|
Change in Maximum Pain in the Achilles Tendon Area
Временное ограничение: Change in maximum pain in the timeframe of the last application (5th week)
|
Measured by numeric rating scale in points.
The values can reach 0-10 points.
A higher score means worse pain.
|
Change in maximum pain in the timeframe of the last application (5th week)
|
|
Change in Maximum Pain in the Achilles Tendon Area (Follow up)
Временное ограничение: Change in maximum pain at 3 weeks follow up after last application (8th week).
|
Measured by numeric rating scale in points.
The values can reach 0-10 points.
A higher score means worse pain.
|
Change in maximum pain at 3 weeks follow up after last application (8th week).
|
|
Change of Ankle Dorsiflexion Range of Motion
Временное ограничение: Change of initial values at 3 weeks follow up after last application (8th week).
|
Measured using weight-bearing lunge test in cm.
|
Change of initial values at 3 weeks follow up after last application (8th week).
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of Participants With Hypoechogenic Areas
Временное ограничение: Change of the echostructure at 3 weeks follow up after last application (8th week).
|
Echostructure is evaluated visually by investigator using musculoskeletal ultrasound machine.
Patients who have a hypoechogenic areas in the tendon are counted.
|
Change of the echostructure at 3 weeks follow up after last application (8th week).
|
|
Number of Participants With Increased Thickness of Achilles Tendon
Временное ограничение: Change of the tendon continuity at 3 weeks follow up after last application (8th week).
|
The Achilles tendon continuity in evaluated visually by investigator using musculoskeletal ultrasound machine.
Patients who have a visually significant increased thickness of tendon will be counted.
|
Change of the tendon continuity at 3 weeks follow up after last application (8th week).
|
|
Change in VISA-A Questionnaire Score
Временное ограничение: Change of initial values at 3 weeks follow up after last application (8th week).
|
The VISA-A questionnaire is standardized questionnaire for patients with Achilles tendinopathy.
The results are recorded in points (0-100 points).
The higher score indicates patients better condition.
|
Change of initial values at 3 weeks follow up after last application (8th week).
|
|
Change in Single Leg Heel Rise Test
Временное ограничение: Change of initial values at 3 weeks follow up after last application (8th week)
|
Patient performs as many heel rises using only one leg as possible in 30 seconds or until first sign of pain in Achilles tendon area.
|
Change of initial values at 3 weeks follow up after last application (8th week)
|
|
Change in Single Leg Hop Test
Временное ограничение: Change of initial values at 3 weeks follow up after last application (8th week).
|
Patient performs as many hops on one leg as possible in 30 seconds or until first sign of pain in Achilles tendon area.
|
Change of initial values at 3 weeks follow up after last application (8th week).
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Stanislav Machač, Mgr., Ph.D., University Hospital Motol and 2nd Faculty of Medicine, Charles University
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- EK- 1/21
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .